Sympathetic nervous system dysfunction in migraine: Pearls and pitfalls in the theorizing process [5]

Headache

Volumn 44, Issue 8, 2004, Pages 841-842

  Gupta, Vinod Kumar ^a  

^a Dubai eGovernment Dubai Police   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN MONOAMINE; MONOAMINE OXIDASE A INHIBITOR; NORADRENALIN; PROPRANOLOL;

ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; DISEASE ASSOCIATION; HORNER SYNDROME; HUMAN; LETTER; LOCUS CERULEUS; MIGRAINE; MIOSIS; NORADRENALIN BLOOD LEVEL; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; PROPHYLAXIS; RAYNAUD PHENOMENON; STRESS; SYMPATHETIC FUNCTION;

HUMANS; MIGRAINE DISORDERS; MODELS, BIOLOGICAL; SYMPATHETIC NERVOUS SYSTEM;

EID: 4744366397     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2004.04158_5.x     Document Type: Letter

References (8)

1. Peroutka SJ. Migraine: A chronic sympathetic nervous system disorder. Headache. 2004;44:53-64.
2. Hsu LKG, Crisp AH, Kalucy RS, et al. Early morning migraine. Nocturnal plasma levels of catecholamines, tryptophan, glucose and free-fatty acids and sleep encephalographs. Lancet. 1977;ii:447-451.
3. Lance JW. A concept of migraine and the search for the ideal headache drug. Headache. 1990;30:17-23.
4. Gupta VK. Parasympathetic hyperfunction during migraine attacks. Headache. 2004;44:730-731.
5. Blau JN. Migraine: theories of pathogenesis. Lancet. 1992;339:1202-1207.
6. Gupta VK. Classification of primary headaches: Pathophysiology versus nosology? Published electronic response to: Peatfield R. A revised classification of headache disorders. Available at http://bmj.com/cgi/content/ full/328/7432/119?etoc. January 22, 2004.
7. Mathiau P, Escurat M, Aubineau P. Immunohistochemical evidence for the absence of central neuron projection to pial blood vessels and dura mater. Neuroscience. 1993;52:667-676.
8. Charlton BG. Stress. J Med Ethics. 1992;18:156-159.